Goat F(ab)2 anti-Horse IgG (H+L)-HRPO, MinX none

Catalog Number: DNA-SEC-182682
Article Name: Goat F(ab)2 anti-Horse IgG (H+L)-HRPO, MinX none
Biozol Catalog Number: DNA-SEC-182682
Supplier Catalog Number: SEC-182682
Alternative Catalog Number: DNA-SEC-182682
Manufacturer: dianova
Host: Goat
Category: Antikörper
Application: ELISA,IHC,WB
Species Reactivity: Equine
Immunogen: Horse IgG whole molecule
Conjugation: HRPO
Alternative Names: goat F(ab)2 anti-Horse IgG Antibody peroxidase Conjugated, goat F(ab)2 anti-Horse IgG HRP conjugated antibody
Format: F(ab')2
Target Specificity: IgG (H+L)
Cross-Adsorption (MinX): no cross-adsorbtion
F(ab)2 Anti-Horse IgG Peroxidase Antibody was generated by enzymatic cleavage and subsequent separation from the Fc fragment. Because of their smaller size, F(ab)2 fragments offer several advantages over intact antibodies for use in certain immunochemica
Clonality: Polyclonal
Concentration: 10.0 mg/mL
Isotype: Ig
Buffer: 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Purity: This product is a F(ab’)2 fragment of an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation, ion exchange chromatography and pepsin digestion followed by extensive dialysis against the buffer stated above.  Assay by immunoelectro-phoresis resulted in a single precipitin arc against anti-Peroxidase, anti-Goat Serum, Horse IgG and Horse Serum.  No reaction was observed against anti-Goat IgG F(c) or anti-Pepsin.
Form: Lyophilized
Formula: 10 mM NaPO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% Gentamicin
Target: Horse
Antibody Type: Secondary Antibody
Application Dilute: ELISA Dilution: 1:10,000 - 1:50,000, Immunohistochemistry Dilution: 1:500 - 1:2,500, Western Blot Dilution: 1:1,000 - 1:10,000
Application Notes: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.